Heartburn tablets 'may increase risk of dementia, heart attacks and kidney problems'
The Houston scientists carried out tests on a type of PPI called esomeprazole, sold in the US and UK under the brand name Nexium or Nexium Control. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2016 Category: Consumer Health News Source Type: news

Clues to How Popular Heartburn Drug Might Harm Arteries
Prior research has also raised concerns about Nexium and heart health Source: HealthDay Related MedlinePlus Page: Heartburn (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 10, 2016 Category: Consumer Health News Source Type: news

Social Media: A New Fix for Pharma
Trish Nettleship has spent her whole career in marketing, first with Hayes Microcomputers, then telecommunication giants BellSouth and AT&T. Now, as Global Director Multichannel Marketing for UCB, she insists that Pharma shouldn’t be wary of Social Media. Instead, Pharma should embrace it – just as she’s passionately done, throughout her career, seeking creative approaches to deliver results. 1) As an expert in social media, let's discuss the changing role of social media in pharma and building engaged communities. How has social media's importance evolved since your time in AT&T and what have bee...
Source: EyeForPharma - March 24, 2016 Category: Pharmaceuticals Authors: Women in Pharma Source Type: news

Can a heartburn drug cause cognitive problems?
A new study has shed light on one of the long-term effects of proton pump inhibitors (PPIs). These drugs are commonly used to treat gastroesophageal reflux disease (GERD), heartburn, and peptic ulcers. PPIs (omeprazole, lansoprazole, esomeprazole, pantoprazole, and others) help reduce the amount of stomach acid made by glands in the lining of the stomach. Research published online on February 15 in JAMA Neurology showed that there may be an association between chronic use of PPIs and an increased risk of dementia. Experts compared prescription PPI intake and diagnosis of dementia among approximately 74,000 adults ages 75 a...
Source: New Harvard Health Information - March 21, 2016 Category: Consumer Health News Authors: Matthew Solan Tags: Brain and cognitive health Digestive Disorders Drugs and Supplements Healthy Aging Memory Mental Health heartburn PPIs proton pump inhibitors Source Type: news

Medications May Cause Dementia, But It Could Be Untreated Sleep Apnea
By Brandon R. Peters, M.D. The news was enough to give you indigestion: Some of the over-the-counter and prescription medications most widely used to treat heartburn and acid reflux are linked to the development of dementia. The research suggesting a possible association is the latest in a string of implicated drugs over the past few years, including medications taken to treat anxiety, seizures, insomnia, and allergies. What is going on? Before emptying out the medicine cabinet, take a moment to consider the role of untreated obstructive sleep apnea. Scientific research can be difficulty to contextualize, especially when i...
Source: Healthy Living - The Huffington Post - February 27, 2016 Category: Consumer Health News Source Type: news

Can You Really Bottle Energy?
You see it almost everywhere these days — energy drinks that advertise the wonder of B vitamins. And they all claim to give you the energy boost to get you through your day. Sadly, it’s a big marketing ploy. The quick energy in these drinks usually comes from their high sugar and synthetic caffeine content. It’s true that B vitamins are essential to your body’s energy metabolism. And B12 in particular is crucial for energy. When you take in high-quality B12, you unlock the energy contained in the foods you eat and turn it into glucose you can burn. But fortified junk food is no way to get your vita...
Source: Al Sears, MD Natural Remedies - February 16, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Nutrition b12 energy telomeres Source Type: news

Gastric Reflux Drugs May Be Tied To Dementia Risk
Reuters Health - Repeated use of a certain class of drugs for gastric reflux or peptic ulcers was linked with a higher risk for dementia among patients in Germany, researchers say. The drugs, known as proton pump inhibitors (PPIs), include lansoprazole (Prevacid), esomeprazole (Nexium), and omeprazole (Prilosec), all manufactured by AstraZeneca. The current study can only provide a statistical association between PPI prescriptions and occurrence of dementia in the elderly. It can’t prove that PPIs actually cause dementia, said senior author Britta Haenisch of the German Center for Neurodegenerative Diseases in Bonn, ...
Source: Science - The Huffington Post - February 16, 2016 Category: Science Source Type: news

Link between indigestion drugs and dementia 'inconclusive'
Conclusion This study found people taking PPIs had a 44% higher risk of developing dementia in a seven-year period compared with those not taking the drugs. However, it's not accurate to say this was down to the PPIs – the study couldn't prove this, and there are many possible explanations. For a start, the groups weren't very similar. Those taking PPIs had poorer health, and were more likely to be taking a number of medicines and have conditions linked to a higher risk of dementia, such as diabetes and heart disease. After taking these factors into account in the analysis, the link between...
Source: NHS News Feed - February 16, 2016 Category: Consumer Health News Tags: Medication Neurology Older people Source Type: news

Widely Used Heartburn Drugs Linked to Dementia Risk in Study
MONDAY, Feb. 15, 2016 -- A popular class of heartburn medications might raise a senior's risk of dementia, a new study suggests. Called proton pump inhibitors (PPIs), this group of drugs includes Prilosec, Nexium and Prevacid. They work by lowering... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2016 Category: Journals (General) Source Type: news

My Favorite Natural Heartburn Remedies
Every time I come back to Africa, I’m reminded just how natural the health care is here. I recently watched one local herbalist cure a patient of chronic heartburn with a tea made from a popular root (more about that soon). Heartburn is a common disorder of the stomach caused by the overproduction of stomach acid. In America, mainstream medicine is likely throwing Big Pharma’s “treatments” at you — like proton-pump inhibitors (PPIs), which block the production of stomach acid. You might know these better as Nexium, Prilosec and Prevacid. But these PPIs have some pretty BIG downsides you&rsquo...
Source: Al Sears, MD Natural Remedies - February 4, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Natural Cures heartburn Remedies stomach acid Source Type: news

Well: Heartburn Drugs Tied to Kidney Problems
Proton pump inhibitors like Nexium, Prevacid and Prilosec may increase the risk of chronic kidney disease. (Source: NYT)
Source: NYT - January 15, 2016 Category: Nutrition Authors: NICHOLAS BAKALAR Tags: Drugs (Pharmaceuticals) Heartburn Kidneys Live Clostridium Difficile (Bacterium) Featured Source Type: news

Well: Heartburn Drugs Tied to Kidney Problems
Proton pump inhibitors like Nexium, Prevacid and Prilosec may increase the risk of chronic kidney disease. (Source: NYT Health)
Source: NYT Health - January 14, 2016 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Drugs (Pharmaceuticals) Heartburn Kidneys Live Clostridium Difficile (Bacterium) Featured Source Type: news

Indian Drugmaker Takes Second Shot With Its Generic Nexium
Dr. Reddy’s Laboratories relaunched its popular generic version of the heartburn remedy Nexium in a new color after a U.S. court last month agreed with AstraZeneca’s objections to the old one. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 31, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news

5 Ways To Stop A Nagging Cough
SPECIAL FROM Holiday shopping. Holiday parties. Airplanes. It seems like wherever you go this time of year, you’re bound to find someone coughing on you. Ick. Next thing you know, you’re coughing, too. How to stop your nagging cough? We asked the experts. “Coughing is one of the most common reasons people visit their health care provider,” says Rachel Taliercio, D.O, a pulmonologist with the Respiratory Institute at the Cleveland Clinic. And there are a variety of diseases that cause people to cough. How you treat that cough depends on what’s causing it in the first place. That said, there ar...
Source: Healthy Living - The Huffington Post - December 24, 2015 Category: Consumer Health News Source Type: news

EndoStim officially spikes $35m IPO
EndoStim today officially spiked an initial public offering it hoped would raise $35 million for its neurostimulation device for gastroesophageal reflux disease. EndoStim, which had planned to put $10 million of the IPO’s proceeds into clinical studies and another $14 million to commercialize the system, tabled the offering in October 2014. Today the company filed a formal withdrawal request with the U.S. Securities & Exchange Commission, citing “market conditions.” EndoStim is operating from a small headquarters in St. Louis where it employs 13 people, including CEO Bevil Hogg, who took Ste...
Source: Mass Device - December 9, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Initial Public Offering (IPO) Funding Roundup EndoStim Source Type: news

Generic Pill Blocked in U.S. Over Its Color
Dr. Reddy’s has been blocked from selling its generic version of the heartburn drug Nexium in the U.S., after AstraZeneca objected to the pill’s purple color. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 11, 2015 Category: Pharmaceuticals Tags: PAID Source Type: news

U.S. court imposes temporary sales ban on Dr Reddy's generic Nexium
MUMBAI (Reuters) - Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said on Tuesday it had been temporarily barred by a U.S. court from selling its generic form of blockbuster heartburn drug Nexium in the United States. (Source: Reuters: Health)
Source: Reuters: Health - November 10, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Dr Reddy's restrained from selling generic drug Nexium in US market
Nexium is used to treat severe gastric diseases. The company said the order has been passed pending further hearing or trial. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 10, 2015 Category: Pharmaceuticals Source Type: news

Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT)
Source: NYT - October 15, 2015 Category: American Health Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news

Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT Health)
Source: NYT Health - October 15, 2015 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news

Ask Well: Taking Heartburn Drugs Long-Term
The most popular acid reflux medications — proton pump inhibitors like Nexium, Prilosec and Prevacid, which are taken daily — can have serious side effects with long-term use. (Source: NYT)
Source: NYT - October 15, 2015 Category: Nutrition Authors: RONI CARYN RABIN Tags: Ask Well Drugs (Pharmaceuticals) Heartburn Gastroesophageal Reflux (Acid Reflux) Live Featured Source Type: news

Sun Pharma withdraws lawsuit filed by Ranbaxy against USFDA
The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 9, 2015 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches Nexium generic in US market
Drug major Dr Reddy's Laboratories (DRL) has launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 28, 2015 Category: Pharmaceuticals Source Type: news

Fast Relief For Heartburn
When heartburn hits, you need a fast and reliable way of dealing with the pain. But before you take another antacid, or prescription like Nexium, Prilosec, or Prevacid, there’s something I want to share with you. Heartburn drugs actually make your condition worse over time. And there’s new evidence they boost your risk of heart attack by up to 20%. I know it’s frustrating to hear another prescription drug is doing terrible things to your body. But today, I’ll show you a few options that will shut down heartburn almost immediately. These options are safe, affordable, and easy to use. Let me expl...
Source: Al Sears, MD Natural Remedies - July 17, 2015 Category: Complementary Medicine Authors: Andrew Britton Tags: Anti-Aging Source Type: news

esomeprazole (Nexium, Nexium 24HR, Nexium IV)
Title: esomeprazole (Nexium, Nexium 24HR, Nexium IV)Category: MedicationsCreated: 5/8/2001 12:00:00 AMLast Editorial Review: 6/30/2015 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 30, 2015 Category: Nutrition Source Type: news

esomeprazole (Nexium, Nexium 24HR, Nexium IV)
Title: esomeprazole (Nexium, Nexium 24HR, Nexium IV)Category: MedicationsCreated: 5/8/2001 12:00:00 AMLast Editorial Review: 6/30/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 30, 2015 Category: Drugs & Pharmacology Source Type: news

Data Dive Suggests Link Between Heartburn Drugs And Heart Attacks
The drugs are proton-pump inhibitors, including Prilosec, Nexium and Prevacid. But the study doesn't show cause and effect. Other factors — diet, drink or tobacco — may play a role.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - June 11, 2015 Category: Consumer Health News Authors: Richard Harris Source Type: news

Common heartburn drugs could raise risk of heart attacks
Millions of people take drugs known as proton pump inhibitors (PPIs) to treat heartburn and acid reflux. Popular brands include Prilosec, Prevacid and Nexium. But now a new study raises concern that they may increase the risk of heart attacks. Brian Webb reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 11, 2015 Category: Consumer Health News Source Type: news

Why Medicare's List Of Costly Drugs Is Kind Of Bogus
No, the most expensive drug for the U.S. Medicare drug benefit program is not Nexium, the heartburn medicine – no matter what Medicare says. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 1, 2015 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

Judge Rules in Favor of FDA in Ranbaxy Drug Approval Suit
U.S. District Judge Beryl Howell ruled that the FDA is within its right torevoke approval of Ranbaxy's generic Nexium and Valcyte. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - March 17, 2015 Category: Pharmaceuticals Source Type: news

Ranbaxy loses approvals, exclusivity of two drugs in US
In November, Ranbaxy had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 3, 2015 Category: Pharmaceuticals Source Type: news

US judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
Launching the first generic copies of the drugs would have given Ranbaxy six months of exclusivity on the market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 28, 2015 Category: Pharmaceuticals Source Type: news

U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
MUMBAI (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed. (Source: Reuters: Health)
Source: Reuters: Health - February 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Morning Break: Califf to FDA; Generic Nexium; Another Clinic Shooting
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 27, 2015 Category: Primary Care Source Type: news

Ranbaxy forfeits 180 days exclusivity for generic Nexium
Ranbaxy said USFDA has determined that it has forfeited its 180-day exclusivity to sell generic version of digestive disorder medicine Nexium in US market (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2015 Category: Pharmaceuticals Source Type: news

Generic Form of Nexium Approved
Title: Generic Form of Nexium ApprovedCategory: Health NewsCreated: 1/26/2015 12:00:00 AMLast Editorial Review: 1/27/2015 12:00:00 AM (Source: MedicineNet Crohn's Disease General)
Source: MedicineNet Crohn's Disease General - January 27, 2015 Category: Gastroenterology Source Type: news

First Generic Nexium Approved (FREE)
By The Editors The FDA has approved the first generic version of the proton-pump inhibitor … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 27, 2015 Category: Primary Care Source Type: news

FDA OKs First Generic Version of Heartburn Drug Nexium
The proton pump inhibitor reduces amount of acid in the stomach (Source: WebMD Health)
Source: WebMD Health - January 26, 2015 Category: Consumer Health News Source Type: news

FDA OKs First Generic Version of Heartburn Drug Nexium
The proton pump inhibitor reduces amount of acid in the stomach Source: HealthDay Related MedlinePlus Pages: GERD, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 26, 2015 Category: Consumer Health News Source Type: news

FDA Clears First Generic Esomeprazole for GERDFDA Clears First Generic Esomeprazole for GERD
Ivax Pharmaceuticals, Inc, a subsidiary of Teva Pharmaceuticals USA, will market esomeprazole in 20- and 40-mg capsules. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 26, 2015 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

FDA approves Teva's generic version of AstraZeneca's Nexium
(Reuters) - The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug. (Source: Reuters: Health)
Source: Reuters: Health - January 26, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves first generic esomeprazole
The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux disease (GERD) in adults and children ages 1 and older. Esomeprazole is a proton pump inhibitor that reduces the amount of acid in the stomach. (Source: Food and Drug Administration)
Source: Food and Drug Administration - January 26, 2015 Category: American Health Source Type: news

AstraZeneca's Move to Protect Nexium Market Ruled Legal
(MedPage Today) -- "Pay to delay" strategy upheld by court. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 9, 2014 Category: American Health Source Type: news

Boston court rules in favor of AstraZeneca's 'pay-for-delay' deal involving Nexium
A federal jury in Massachusetts has ruled in favor of AstraZeneca Plc and Ranbaxy Laboratories following accusations that the companies delayed the launch of a generic version of the heartburn drug Nexium, sparing the companies potentially billions in damages. The verdict was handed down Friday in federal court in Boston. The lawsuit began in 2012 and was filed by plaintiffs including drug wholesalers, retailers and insurance companies. The plaintiffs claimed that the two companies agreed to a… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 7, 2014 Category: Biotechnology Authors: Mary Moore Source Type: news

Boston court rules in favor of AstraZeneca's 'pay-for-delay' deal involving Nexium
A federal jury in Massachusetts has ruled in favor of AstraZeneca Plc and Ranbaxy Laboratories following accusations that the companies delayed the launch of a generic version of the heartburn drug Nexium, sparing the companies potentially billions in damages. The verdict was handed down Friday in federal court in Boston. The lawsuit began in 2012 and was filed by plaintiffs including drug wholesalers, retailers and insurance companies. The plaintiffs claimed that the two companies agreed to a… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 6, 2014 Category: Pharmaceuticals Authors: Mary Moore Source Type: news

AstraZeneca, Ranbaxy prevail in Nexium antitrust trial
The US Federal Trade Commission estimates that pay-for-delay deals, in which a branded drugmaker pays a generic rival to stay off the market, cost consumers $3.5 billion each year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 5, 2014 Category: Pharmaceuticals Source Type: news

US court refuses Ranbaxy appeal to block ANDA nod for 2 drugs
Ranbaxy Laboratories had sued USFDA over revoking an approval to sell generic versions of Nexium and Valcyte in the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 26, 2014 Category: Pharmaceuticals Source Type: news

U.S. Court Overturns Ranbaxy's Bid to Block Rival Generics
A U.S. court has denied a request by India's Ranbaxy Laboratories to stop competitors from launching generic copies of AstraZeneca's heartburn pill Nexium and Roche's antiviral, Valcyte. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 20, 2014 Category: Pharmaceuticals Source Type: news

Ranbaxy Sues FDA Over Revoked Generic Approvals
Ranbaxy Laboratories has sued the U.S. FDA for revoking approvals granted to launch generic copies of AstraZeneca's Nexium and Roche's Valcyte. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 18, 2014 Category: Pharmaceuticals Source Type: news